Your browser is no longer supported. Please, upgrade your browser.
Settings
GSK GlaxoSmithKline plc daily Stock Chart
GSK [NYSE]
GlaxoSmithKline plc
Index- P/E3104.29 EPS (ttm)0.01 Insider Own0.20% Shs Outstand2.45B Perf Week-1.00%
Market Cap106.40B Forward P/E15.67 EPS next Y2.77 Insider Trans0.00% Shs Float2.42B Perf Month-3.38%
Income40.90M PEG310.43 EPS next Q0.80 Inst Own9.10% Short Float0.32% Perf Quarter3.64%
Sales33.20B P/S3.20 EPS this Y204.10% Inst Trans5.53% Short Ratio2.34 Perf Half Y13.65%
Book/sh0.31 P/B140.19 EPS next Y6.61% ROA0.10% Target Price48.67 Perf Year18.07%
Cash/sh2.52 P/C17.26 EPS next 5Y10.00% ROE0.90% 52W Range34.73 - 45.07 Perf YTD13.88%
Dividend2.20 P/FCF- EPS past 5Y40.20% ROI41.40% 52W High-3.57% Beta0.85
Dividend %5.06% Quick Ratio0.60 Sales past 5Y-3.40% Gross Margin66.60% 52W Low25.14% ATR0.46
Employees101192 Current Ratio0.90 Sales Q/Q10.90% Oper. Margin5.30% RSI (14)41.98 Volatility0.93% 0.87%
OptionableYes Debt/Eq34.12 EPS Q/Q-392.80% Profit Margin0.10% Rel Volume0.70 Prev Close43.36
ShortableYes LT Debt/Eq26.30 EarningsJul 27 Payout- Avg Volume3.35M Price43.46
Recom2.00 SMA20-1.50% SMA500.07% SMA2007.48% Volume2,340,856 Change0.23%
Jul-14-16Upgrade Jefferies Hold → Buy
Mar-30-16Upgrade Citigroup Neutral → Buy
Feb-26-16Initiated Cantor Fitzgerald Hold
Dec-09-15Upgrade BofA/Merrill Neutral → Buy
Dec-07-15Reiterated Argus Buy $52 → $48
Oct-20-15Upgrade Credit Suisse Underperform → Neutral
Sep-15-15Upgrade Exane BNP Paribas Underperform → Neutral
Sep-08-15Upgrade BofA/Merrill Underperform → Neutral
Jun-26-15Upgrade Liberum Sell → Hold
Jun-04-15Downgrade Morgan Stanley Overweight → Equal-Weight
May-20-15Resumed Citigroup Neutral
Apr-15-15Initiated Societe Generale Sell
Feb-19-15Reiterated Argus Buy $55 → $52
Aug-08-14Reiterated Argus Buy $65 → $55
Apr-23-14Upgrade Argus Hold → Buy
May-28-13Upgrade Deutsche Bank Hold → Buy
Jan-11-11Upgrade Jefferies Hold → Buy
Jun-02-10Upgrade Jefferies Hold → Buy
Feb-16-10Upgrade JP Morgan Underweight → Neutral $26
Jan-13-10Downgrade Credit Suisse Outperform → Underperform
Aug-31-16 10:35AM  4 Off-the-Radar Analyst Picks Yielding More Than 4% at 24/7 Wall St.
08:50AM  7 Healthy Dividend Stocks for Quality and Security at Kiplinger
12:00AM  Struggling Vaccines From Novartis Turn Into Sales Boon for Glaxo at Bloomberg
Aug-30-16 06:04PM  $1 Billion Sales Target in Place for Tyvaso
04:04PM  Generic Competition Not a Threat to UTHRs Remodulin
Aug-29-16 02:16PM  Gilead Sciences (GILD) Stock Down, Piper Jaffray 'Doubts' HIV Competitors
01:34PM  Gilead Sciences: Don't Expect Perfection at Barrons.com
12:11PM  Inside the FDA Ebola Edition: Frontrunners Merck & Co., Inc. (MRK), GlaxoSmithKline PLC (ADR) (GSK) at Insider Monkey
09:49AM  Better Buy: GlaxoSmithKline plc vs. AbbVie at Motley Fool
09:15AM  How Will GlaxoSmithKline (GSK) Stock React to New HIV Drug Development?
01:10AM  Zika Virus Vaccine Overturns Pharma Industry Playbook (GSK, SNY, ION) at Investopedia
12:09AM  Glaxo Bets It Can Shake Up HIV Treatment at The Wall Street Journal
Aug-28-16 02:40PM  [$$] Glaxo Bets It Can Shake Up HIV Treatment at The Wall Street Journal
09:19AM  3 High-Yield Dividend Stocks to Buy in September at Motley Fool
Aug-26-16 09:30AM  The Zacks Analyst Blog Highlights: GlaxoSmithKline, Blackstone Group, Mylan, Lululemon and Whole Foods
Aug-25-16 02:39PM  Top Research Reports for August 25, 2016
Aug-24-16 03:30PM  Waiting For Growth, Or A Better Valuation, Argus Stays Sidelined On Novartis Shares
11:04AM  Performance of AstraZenecas RI&A Segment in 2Q16
Aug-23-16 03:13PM  Is AstraZenecas Valuation Improving Compared to Peers?
Aug-22-16 09:04AM  Inside the Performance of Sanofis Human Vaccines Segment in 2Q16
Aug-20-16 09:01AM  3 High-Yielding Healthcare Stocks I'm Not Buying at Motley Fool
Aug-19-16 11:04AM  What Happened to Sanofis Consumer Healthcare and Generics Franchise in 2Q16?
Aug-17-16 05:05PM  Inside Sanofis Valuation Changes
09:59AM  Glaxo/Pfizer ViiV Healthcare Starts HIV Drug Combo Study
09:04AM  Is Valeants Xifaxan Resuming Growth?
Aug-16-16 12:03PM  FTSE 100 snaps win streak, but miners cap losses at MarketWatch
08:55AM  ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment PR Newswire
Aug-14-16 03:02PM  Bristol-Myers' Revolutionary Cancer Drug Suffers A Big Blow at Motley Fool
Aug-12-16 04:54PM  Apple Files Patent Application For A Heart-Monitoring Wearable Device
Aug-11-16 12:30PM  FTSE 100 books 6th straight gain as Saudi comments boost oil stocks at MarketWatch
11:04AM  Pfizers Products with Decreasing Revenues
Aug-10-16 03:49PM  Ionis (IONS) Q2 Loss Narrower than Expected, Issues Outlook
Aug-09-16 11:49PM  GlaxoSmithKline Trades Ex-Dividend Wednesday (GSK) at Investopedia
01:57PM  GlaxoSmithKline's Dividend Health
Aug-08-16 10:32AM  Why Merck's Lung Cancer Success Won't Last at Barrons.com
08:00AM  9 Stocks for the Bank of England's Corporate-Bond Purchases
Aug-05-16 06:29PM  [$$] Week in review: August 6 at Financial Times
10:20AM  Jefferies Keeps Red-Hot Dividend Pharmaceutical Stock as Top Sector Pick at 24/7 Wall St.
Aug-04-16 02:57PM  ETFs with exposure to GlaxoSmithKline Plc : August 4, 2016
Aug-03-16 05:42PM  Googles parent company wants to treat disease by zapping you with electricity
01:13PM  We've Just Found the 'Apple' of Biotechnology at TheStreet
11:33AM  Here's Why GlaxoSmithKline's Stock Is Ready to Scale New Heights
11:21AM  GlaxoSmithKline Plc :GSK-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016
09:05AM  GlaxoSmithKlines Consumer Healthcare Grows in 2Q16
Aug-02-16 10:46AM  The C-Suite Speaks: No One Called This an Expansion
10:44AM  Alphabet and Glaxo Team Up to Jumpstart Your Profits at TheStreet
09:07AM  How Did GlaxoSmithKlines Pharmaceuticals Segment Do in 2Q16?
07:10AM  Alphabet looks to piggyback tiny implants onto body's nerves at San Jose Mercury News
Aug-01-16 11:42PM  Glaxo, Alphabet Plan $700 Million Bioelectric Treatment Venture at The Wall Street Journal
07:07PM  Shock treatment: Bioelectronic med devices jolted with new venture between GSK, former Google life sciences unit at bizjournals.com
05:05PM  Portfolio Roundup: Humira Helps Buoy AbbVie Shares at TheStreet
04:58PM  Veeva Helps The Medicine Go Down Faster for Drug Giants
04:39PM  Alphabet-Glaxo Joint Venture Targets 'Bioelectronics'
01:12PM  Why Are These Five Stocks on Investors Radars Today? at Insider Monkey
11:47AM  Google sister company, drug maker to develop nerve implants at San Jose Mercury News
11:35AM  GlaxoSmithKline (GSK) Chairman Slaoui to CNBC: Bioelectronics a 'Whole new Industry'
10:23AM  Google sister company, drug maker to develop nerve implants
10:04AM  GlaxoSmithKlines Revenue Trend in 2Q16
09:41AM  Pharma and tech converge in "fantastic voyage" to fight disease
08:42AM  Morning Movers: GSK, GOOGL, SCTY, TSLA
07:55AM  Pharma and tech giants are teaming up to design devices that can hack your bodys electrical signals
07:52AM  Future of electronic medicine
05:34AM  GSK and Google parent forge $715 million bioelectronic medicines firm
05:30AM  GSK and Google parent forge $715 mln bioelectronic medicines firm Reuters
04:27AM  Glaxo Teams Up with Alphabet on Bioelectronic Med Deal at TheStreet
04:24AM  Glaxo, Alphabet Plan $700 Million Bioelectric Treatment Venture at The Wall Street Journal
02:37AM  Glaxo, Alphabet Form Venture to Develop Bioelectronic Medicines at Bloomberg
02:12AM  GSK creates $715 mln bioelectronics company with Alphabet unit Reuters
Jul-30-16 08:40PM  GlaxoSmithKline Increases Top Line in 2Q16
Jul-29-16 03:27PM  Legg Mason Introduces International High Dividend, Low Vol ETF
11:04AM  Genvoya Becomes Most Prescribed Regimen for HIV Patients in US
09:12AM  Brexit: GlaxoSmithKline Invests $361M in the UK (GSK) at Investopedia
Jul-28-16 10:59AM  Glaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
05:01AM  AstraZeneca Earnings, Sales Edge Above Forecasts
12:11AM  [$$] GlaxoSmithKline Helped and Hurt by Sterlings Post-Brexit Fall at The Wall Street Journal
Jul-27-16 06:10PM  [$$] GlaxoSmithKline Helped and Hurt by Sterling's Post-Brexit Fall at The Wall Street Journal
12:37PM  Why Fiat Chrysler, Coca-Cola, Anthem and 2 Other Stocks Are Moving Today at Insider Monkey
10:45AM  4 Surprising Quality Growth Stocks That Pay at Least a 5% Dividend at 24/7 Wall St.
10:45AM  McDonalds Joins Glaxo in Giving Jobs Boost to Post-Brexit U.K. at Bloomberg
09:50AM  Stocks Rise At Open As Apple Hauls Techs Higher
09:32AM  GSK invests $A481m in post-Brexit UK AAP
09:21AM  GlaxoSmithKline invests $360 million in UK despite Brexit Reuters
09:14AM  Glaxo reports 2Q loss
09:13AM  GlaxoSmithKline CEO on Performance, Products, Growth at Bloomberg
09:11AM  GlaxoSmithKline CEO: Strong Currency Tailwind Effect at Bloomberg
08:23AM  GlaxoSmithKline Rallies on Strong Quarterly Results
08:20AM  GSK results ride sterling's roller-coaster at CNBC
07:44AM  Should You Buy GlaxoSmithKline After Today's Brilliant Results? at Forbes
07:16AM  GSK outlook brightens as Brexit brings currency windfall
07:07AM  Glaxos Earnings Exceed Estimates, Helped by New Drug Sales at Bloomberg
07:00AM  GSK chases next biotech asthma drug with $230 mln J&J deal
04:20AM  GlaxoSmithKline invests $360 mln in UK despite Brexit vote Reuters
02:03AM  GlaxoSmithKline invests $360 mln in post-Brexit UK manufacturing Reuters
02:00AM  Glaxo to Invest $360 Million in Three U.K. Manufacturing Sites at Bloomberg
Jul-26-16 10:36AM  5 Drug Stocks' Earnings on Jul 27: AMGN, VRTX & More
09:04AM  Newly Acquired Products Boost GlaxoSmithKlines Earnings
Jul-25-16 11:05AM  GSKs Novartis Acquisition Key to Growth in Its Vaccines Segment
11:04AM  How Do the Majority of Analysts Rate Novartis after 2Q16?
09:07AM  GSK 2Q16 Earnings: Did Pharmaceuticals Grow?
08:49AM  Glaxo (GSK) Q2 Earnings: Can the Stock Pull a Surprise?
GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide. The company offers pharmaceutical products in the therapeutic areas, including respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health areas. The company's wellness products include Panadol and Panadol Cold & Flu for headache, joint pain, fever, and cold symptoms; ENO and Tums that are immediate relief antacids; and Nicorette (US), Nicoderm, NiQuitin CQ, and Nicabate for the treatment of nicotine withdrawal as an aid to smoking reduction and cessation. Its oral health products comprise Sensodyne to treat and prevent dental sensitivity and acid erosion; Polident, Poligrip, and Corega to enhance comfort of fitted dentures and to clean dentures; and Aquafresh for the prevention of caries, gum disease, and bad breath. The company's nutrition products include Horlicks, a nutritional beverages and food; and skin health products comprise Physiogel, a face and body care product for dry, sensitive, and irritated skin, as well as Zovirax and Abreva to treat and prevent the onset of cold sores. GlaxoSmithKline plc has collaboration agreements with Universite de Sherbrooke and Pfizer Inc.; development agreement, and R and D collaboration with Propeller Health; R and D collaboration agreement with Valneva SE; and collaboration and license agreement with Idera pharmaceuticals, Inc. The company was founded in 1935 and is headquartered in Brentford, the United Kingdom.